Corporate ActionJun 8, 2026, 04:11 PM
AIM ImmunoTech Files to Register 31.3M Shares for Resale
AI Summary
AIM ImmunoTech Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 31,287,933 shares of common stock. These shares are underlying various warrants issued in recent transactions, including a warrant inducement and a registered direct offering. The company itself will not receive proceeds from the resale, but could generate approximately $14.5 million if the warrants are exercised for cash. The filing also addresses the company's efforts to maintain compliance with NYSE American listing requirements, particularly regarding stockholders' equity.
Key Highlights
- AIM ImmunoTech Inc. is registering up to 31,287,933 shares of common stock for resale by selling stockholders.
- These shares are issuable upon the exercise of Class H Warrants, Warrant Inducement Placement Agent Warrants, Class I Warrants, and May Offering Placement Agent Warrants.
- The company will not receive proceeds from the sale of these shares, but could receive approximately $14.5 million if all warrants are exercised for cash.
- AIM ImmunoTech Inc. is listed on NYSE American under the symbol "AIM", with the last reported sale price on June 5, 2026, at $0.52 per share.
- The company has been working to regain compliance with NYSE American's stockholders' equity rule, currently at $6.5 million after recent offerings.
Price Impact
More from AIM